Little Green Pharma (ASX:LGP) COGS-to-Revenue : 0.59 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Little Green Pharma COGS-to-Revenue?

Little Green Pharma's Cost of Goods Sold for the six months ended in Sep. 2023 was A$7.43 Mil. Its Revenue for the six months ended in Sep. 2023 was A$12.65 Mil.

Little Green Pharma's COGS to Revenue for the six months ended in Sep. 2023 was 0.59.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Little Green Pharma's Gross Margin % for the six months ended in Sep. 2023 was 41.24%.

Little Green Pharma COGS-to-Revenue Historical Data

The historical data trend for Little Green Pharma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Little Green Pharma COGS-to-Revenue Chart

Little Green Pharma Annual Data

Trend

Jun19

Jun20

Jun21

Mar23

COGS-to-Revenue

0.48

0.18

0.39

Little Green Pharma Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Mar23	Sep23
COGS-to-Revenue	Get a 7-Day Free Trial			0.33	-	0.39	-	0.59

Little Green Pharma COGS-to-Revenue Calculation

Little Green Pharma's COGS to Revenue for the fiscal year that ended in Mar. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.59	/	19.568
	=	0.39

Little Green Pharma's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.434	/	12.651
	=	0.59

Little Green Pharma (ASX:LGP) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Little Green Pharma's Gross Margin % for the six months ended in Sep. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	7.434 / 12.651
	=	41.24 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Little Green Pharma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Little Green Pharma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Little Green Pharma (ASX:LGP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Little Green Pharma Ltd (ASX:LGP) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

66 Kings Park Road, Level 2, Suite 2, West Perth, Perth, WA, AUS, 6005

Website

https://www.littlegreenpharma.com

Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

Little Green Pharma (ASX:LGP) Headlines

No Headlines